Item(by='jcranmer', descendants=None, kids=[24802021, 24801780, 24801734], score=None, time=1602861672, title=None, item_type='comment', url=None, parent=24801541, text='Derek Lowe is mentioning remdisivir as one of the leading candidates for COVID-19 therapy here on March 6th, before the HCQ brouhaha starts: <a href="https:&#x2F;&#x2F;blogs.sciencemag.org&#x2F;pipeline&#x2F;archives&#x2F;2020&#x2F;03&#x2F;06&#x2F;covid-19-small-molecule-therapies-reviewed" rel="nofollow">https:&#x2F;&#x2F;blogs.sciencemag.org&#x2F;pipeline&#x2F;archives&#x2F;2020&#x2F;03&#x2F;06&#x2F;co...</a> (he also mentions chloroquine as a protocol under investigation).<p>For those unfamiliar: Derek Lowe is a drug discovery chemist who writes a well-known blog on drug discovery and other chemical topics (most notably the &quot;Things I Won&#x27;t Work With&quot; series, which covers nasty chemicals like ClF₃ or C₂N₁₄), which has of course been dominated by COVID-19 in 2020.')